| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/FJC.0B013E31823F888F |
| P8608 | Fatcat ID | release_hie2zhbj6bbh7p2ri4pcjoyyki |
| P698 | PubMed publication ID | 22075750 |
| P2093 | author name string | Jian Wu | |
| Junbo Ge | |||
| Lei Li | |||
| Li Lin | |||
| Yunzeng Zou | |||
| Yunbo Li | |||
| Hui Gong | |||
| Yanyan Liang | |||
| Yong Ye | |||
| Ning Zhou | |||
| Zhenhua Jia | |||
| Yiling Wu | |||
| Jingmin Zhou | |||
| Jianming Wei | |||
| P433 | issue | 3 | |
| P304 | page(s) | 268-280 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology | Q2125808 |
| P1476 | title | Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice. | |
| P478 | volume | 59 |
| Q54942355 | A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity. |
| Q50351086 | A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach. |
| Q36269847 | Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-β1/Smad3 Pathway |
| Q36964070 | Cardio-protecteffect of qiliqiangxin capsule on left ventricular remodeling, dysfunction and apoptosis in heart failure rats after chronic myocardial infarction |
| Q42576790 | Cardiotonic modulation in heart failure: insights from traditional Chinese medicine |
| Q35705411 | Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice |
| Q28354136 | Effects of Active Components of Fuzi and Gancao Compatibility on Bax, Bcl-2, and Caspase-3 in Chronic Heart Failure Rats |
| Q35667909 | Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure. |
| Q33606538 | Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model |
| Q39324815 | Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration |
| Q35995098 | High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway |
| Q37083051 | Jia-Shen decoction-medicated serum inhibits angiotensin-II induced cardiac fibroblast proliferation via the TGF-β1/Smad signaling pathway |
| Q35931497 | Losartan treatment attenuates tumor-induced myocardial dysfunction |
| Q36476862 | Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress |
| Q35107771 | Mechanical stress triggers cardiomyocyte autophagy through angiotensin II type 1 receptor-mediated p38MAP kinase independently of angiotensin II. |
| Q33863730 | Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats |
| Q49413287 | Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice |
| Q35919059 | Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction. |
| Q35571961 | Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6 |
| Q38921728 | Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1/ErbB-PI3K/Akt/mTOR pathway |
| Q39754726 | Stepped collisional energy MS(All) : an analytical approach for optimal MS/MS acquisition of complex mixture with diverse physicochemical properties. |
| Q89553854 | Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST) |
| Q33717198 | Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats |
| Q27309112 | Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice. |
| Q55258249 | Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α. |
| Q41867939 | X indening oral liquid improves cardiac function of rats with chronic cardiac failure via TGF-ß1/Smad3 and p38 MAPK pathway |
Search more.